Skip to main content
. 2010 May;176(5):2425–2434. doi: 10.2353/ajpath.2010.090932

Figure 1.

Figure 1

A: C3H10T1/2 cells, stably transfected with the SMAD reporter pcDNA3.1(CAG)15-luc, were treated with 20 ng/ml myostatin that had been preincubated for 30 minutes with or without increasing amounts of PF-354. Preincubation with PF-354 neutralized myostatin activity dose-dependently with an IC50 of 11 nmol/L. Data are means ± SEM, n = 3, and representative of at least three separate experiments. Whole body and quadriceps muscle mass of eight-week-old C57BL/six mice after two weeks treatment with saline (Control), or 3 mg/Kg/wk or 10 mg/kg/wk of PF-354 (B). Data are means ± SEM; n = 5. *P < 0.05 versus Saline.